Marimed OTC Stock Top Management

MRMD Stock  USD 0.13  0.01  7.14%   
Marimed employs about 260 people. The company is managed by 10 executives with a total tenure of roughly 607 years, averaging almost 60.0 years of service per executive, having 26.0 employees per reported executive. Evaluation of Marimed's management performance can provide insight into the firm performance.
Timothy Shaw  Insider
Chief Officer
Steve West  Insider
VP Relations
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marimed. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.

Marimed Management Team Effectiveness

The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0303 %, meaning that it created $0.0303 on every $100 dollars invested by stockholders. Marimed's management efficiency ratios could be used to measure how well Marimed manages its routine affairs as well as how well it operates its assets and liabilities.

Marimed Workforce Comparison

Marimed is regarded second in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 847. Marimed totals roughly 260 in number of employees claiming about 31% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.

Marimed Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Marimed Price Series Summation is a cross summation of Marimed price series and its benchmark/peer.

Marimed Notable Stakeholders

A Marimed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Marimed often face trade-offs trying to please all of them. Marimed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Marimed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Timothy ShawChief OfficerProfile
Steve WestVP RelationsProfile
Howard SchacterChief OfficerProfile
Sara GullicksonVP MarketingProfile
Susan CPAChief OfficerProfile
Jon LevinePresident, CoFounderProfile
Charles FinnieChief OfficerProfile
Ryan CrandallVP OfficerProfile
Robert FiremanChairman CoFounderProfile
Jonathan RiderChief OfficerProfile

About Marimed Management Performance

The success or failure of an entity such as Marimed often depends on how effective the management is. Marimed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Marimed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Marimed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 260 people.
The data published in Marimed's official financial statements typically reflect Marimed's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Marimed's quantitative information. For example, before you start analyzing numbers published by Marimed accountants, it's essential to understand Marimed's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the presentation of Marimed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Marimed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Marimed's management manipulating its earnings.

Marimed Workforce Analysis

Traditionally, organizations such as Marimed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Marimed within its industry.

Marimed Manpower Efficiency

Return on Marimed Manpower

Revenue Per Employee467.2K
Revenue Per Executive12.1M
Net Income Per Employee27.8K
Net Income Per Executive722.5K

Complementary Tools for Marimed OTC Stock analysis

When running Marimed's price analysis, check to measure Marimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marimed is operating at the current time. Most of Marimed's value examination focuses on studying past and present price action to predict the probability of Marimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marimed's price. Additionally, you may evaluate how the addition of Marimed to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
CEOs Directory
Screen CEOs from public companies around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk